Search results (519)
« Back to Publicationsention bias at baseline does not moderate the effect of attention bias modification for residual depressive symptoms
Journal article
Solbø Hagen H. et al, (2026), Journal of Behavior Therapy and Experimental Psychiatry, 90
Implicit learning across varying temporal scales in individuals with and without mood instability.
Journal article
Atkinson LZ. et al, (2026), J Affect Disord, 395
Structural brain differences associated with panic disorder: an ENIGMA-Anxiety Working Group mega-analysis of 4924 individuals worldwide.
Journal article
Han LKM. et al, (2026), Mol Psychiatry
Treatment response to bupropion: an investigation of changes in resting-state functional connectivity in patients with major depressive disorder.
Journal article
Klonteig SE. et al, (2025), Psychopharmacology (Berl)
Nitrous oxide for the treatment of depression: a systematic review and meta-analysis.
Journal article
Gill K. et al, (2025), EBioMedicine, 122
Cognitive pathways describing ketamine’s effect on affective memories
Preprint
Hortelano PA. et al, (2025)
Lithium effects on impulsivity and emotional processing.
Journal article
Ramli FF. et al, (2025), Sci Rep, 15
Neuroanatomical dimensions in major depression linked to cognition, adverse life events, self-harm, metabolomics and genetics.
Journal article
Xiao W. et al, (2025), Commun Med (Lond), 5
Negative affective bias in depression following treatment with psilocybin or escitalopram - a secondary analysis from a randomized trial.
Journal article
Martens MAG. et al, (2025), Transl Psychiatry, 15
5-HTTLPR does not moderate the effect of attention bias modification for depression: a randomized sham-controlled trial.
Journal article
Bø R. et al, (2025), Transl Psychiatry, 15
Synaptic histamine shapes the neurocomputational dynamics of human learning
Preprint
Colwell MJ. et al, (2025)
The cognitive neuroscience of ketamine in major depression.
Journal article
Costi S. et al, (2025), Brain, 148, 3496 - 3504
Neurotransmitter modulation of human facial emotion recognition.
Journal article
Vlazaki M. et al, (2025), J Psychopharmacol, 39, 1089 - 1102
Pramipexole augmentation for the acute phase of treatment-resistant, unipolar depression: a placebo-controlled, double-blind, randomised trial in the UK.
Journal article
Browning M. et al, (2025), Lancet Psychiatry, 12, 579 - 589
The behavioural effects of the serotonin 1A receptor agonist buspirone on cognition and emotional processing in healthy volunteers.
Journal article
Smith ALW. et al, (2025), Psychopharmacology (Berl), 242, 1859 - 1873